
Rogue42 applies neuroscience and AI to advance high-risk mental wellbeing and synthetic sentience research. It develops non-invasive cognitive tests and biomarkers (voice, gaze, and kinematic) and uses predictive processing frameworks to model subjective experiences such as qualia, awareness, and emotions. Core tech includes neuropsychology assessments, biomarker analytics, and AI-driven predictive processing models. The company operates as a deep science research lab for collaborations with research institutions and industry partners seeking advanced neuroscience and AI capabilities.

Rogue42 applies neuroscience and AI to advance high-risk mental wellbeing and synthetic sentience research. It develops non-invasive cognitive tests and biomarkers (voice, gaze, and kinematic) and uses predictive processing frameworks to model subjective experiences such as qualia, awareness, and emotions. Core tech includes neuropsychology assessments, biomarker analytics, and AI-driven predictive processing models. The company operates as a deep science research lab for collaborations with research institutions and industry partners seeking advanced neuroscience and AI capabilities.